Log in

OTCMKTS:WNDM - Wound Management Technologies Stock Price, Forecast & News

Today's Range N/A
50-Day Range
MA: $3.68
52-Week Range N/A
Volume4,685 shs
Average Volume84,782 shs
Market Capitalization$2.55 billion
P/E RatioN/A
Dividend YieldN/A
WNDM Medical Inc. develops, markets, and distributes biotechnology products to physicians, hospitals, and clinics in the United States. The company offers HemaQuell, a resorbable bone hemostat for bone healing; and CellerateRX surgical for healing. The company was formerly known as Wound Management Technologies, Inc. and changed its name to WNDM Medical Inc. in April 2017. WNDM Medical Inc. was founded in 1982 and is based in Fort Worth, Texas.

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Current SymbolOTCMKTS:WNDM



Sales & Book Value

Annual Sales$5.84 million


Net Income$-600,000.00


Market Cap$2.55 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive WNDM News and Ratings via Email

Sign-up to receive the latest news and ratings for WNDM and its competitors with MarketBeat's FREE daily newsletter.

Wound Management Technologies (OTCMKTS:WNDM) Frequently Asked Questions

What is Wound Management Technologies' stock symbol?

Wound Management Technologies trades on the OTCMKTS under the ticker symbol "WNDM."

Has Wound Management Technologies been receiving favorable news coverage?

News headlines about WNDM stock have trended negative on Sunday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Wound Management Technologies earned a news impact score of -2.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for Wound Management Technologies.

Who are some of Wound Management Technologies' key competitors?

What other stocks do shareholders of Wound Management Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wound Management Technologies investors own include Abeona Therapeutics (ABEO), Shanta Gold (SHG), Pacific Rim Cobalt (BOLT), OHR Pharmaceutical (OHRP), Synergy Pharmaceuticals (SGYP), Tenet Healthcare (THC), Northern Dynasty Minerals (NAK), TCF Financial (TCF), F.N.B. (FNB) and Physicians Realty Trust (DOC).

Who are Wound Management Technologies' key executives?

Wound Management Technologies' management team includes the folowing people:
  • Mr. J. Michael Carmena, Chief Exec. Officer (Age 63)
  • Zachary B. Fleming, VP of Sales
  • Sherlene Bagley, Exec. Officer
  • Jay M. Speelhoffer, Director of Strategic Accounts
  • Mr. Michael D. McNeil, Chief Financial Officer (Age 54)

How do I buy shares of Wound Management Technologies?

Shares of WNDM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

How big of a company is Wound Management Technologies?

Wound Management Technologies has a market capitalization of $0.00 and generates $5.84 million in revenue each year. Wound Management Technologies employs 13 workers across the globe.View Additional Information About Wound Management Technologies.

What is Wound Management Technologies' official website?

The official website for Wound Management Technologies is http://www.wmgtech.com/.

How can I contact Wound Management Technologies?

Wound Management Technologies' mailing address is 1200 Summit Avenue Suite 414, Fort Worth TX, 76102. The company can be reached via phone at 817-529-2300.

MarketBeat Community Rating for Wound Management Technologies (OTCMKTS WNDM)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  20 (Vote Underperform)
Total Votes:  42
MarketBeat's community ratings are surveys of what our community members think about Wound Management Technologies and other stocks. Vote "Outperform" if you believe WNDM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WNDM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2019 by MarketBeat.com Staff

Featured Article: Tariff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel